Mounjaro

Mounjaro (tirzepatide) is a new medication licensed for weight loss in certain groups of people. The active ingredient (tirzepatide) was originally designed for use in the treatment of type 2 diabetes,¹ used to help manage blood sugar levels more effectively, but due to positive impact on peoples weight being seen it was approved for use in the treatment of obesity in 2023.

Taken once a week through a simple injection, Mounjaro is now licensed for use as a weight loss medication. Order today for No Hassle, No Delays, No Appointments or Questions asked!